Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_assertion type Assertion NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_head.
- NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_assertion description "[Differences in mutation profiles and patterns of gene gains/losses are seen between BRCA2 (associated with TP53/PTEN mutations, loss of RB1 and gain of HRAS, STK11 and SMARCB1) and BRCAX (associated with PIK3CA mutations) tumours, suggesting that BRCA2 and BRCAX MBCs may be distinct and arise from different tumour pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_provenance.
- NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_assertion evidence source_evidence_literature NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_provenance.
- NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_assertion SIO_000772 25490678 NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_provenance.
- NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_assertion wasDerivedFrom befree-2016 NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_provenance.
- NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_assertion wasGeneratedBy ECO_0000203 NP1246470.RA9iJ9A6C70RyW6Nf4NQW0AmillJhqteAuhBjSVE915ck130_provenance.